Corrigendum to: Influence of DNA Copy Number Aberrations in ABC Transporter Family Genes on the Survival of Patients with Primary Operatable Non-Small Cell Lung Cancer.

IF 2.5 4区医学 Q3 ONCOLOGY

Current cancer drug targets Pub Date : 2026-06-19 DOI:10.2174/1568009626999260619162126

Matvey Mikhailovich Tsyganov, Marina Konstantinovna Ibragimova, Evgeny Olegovich Rodionov, Anastavia Alekseevna Frolova, Irina Aleksandrovna Tsydenova, Elizaveta Andreevna Lutzkaya, Sergey Viktorovich Miller

{"title":"Corrigendum to: Influence of DNA Copy Number Aberrations in ABC Transporter Family Genes on the Survival of Patients with Primary Operatable Non-Small Cell Lung Cancer.","authors":"Matvey Mikhailovich Tsyganov, Marina Konstantinovna Ibragimova, Evgeny Olegovich Rodionov, Anastavia Alekseevna Frolova, Irina Aleksandrovna Tsydenova, Elizaveta Andreevna Lutzkaya, Sergey Viktorovich Miller","doi":"10.2174/1568009626999260619162126","DOIUrl":null,"url":null,"abstract":"<p><p>In the article titled \"Influence of DNA Copy Number Aberrations in ABC Transporter Family Genes on the Survival of Patients with Primary Operatable Non-Small Cell Lung Cancer\", published in Current Cancer Drug Targets, 2026, 26(2), 256-267 [1], Figure 6 was erroneously cited in the text. The original article can be found online at: https://www.benthamscience.com/issue/14684. Details of the correction are as follows: Original: Therefore, in vitro experiments showed changes in ABC-transporter genes expression profile after chemotherapy drugs expo-sure. Increase in the expression levels of genes in chemotherapy drugs resistant clones may indicate their involvement in multidrug resistance development (Fig. 6). Corrected: Therefore, in vitro experiments showed changes in ABC-transporter genes expression profile after chemotherapy drugs expo-sure. Increase in the expression levels of genes in chemotherapy drugs resistant clones may indicate their involvement in multidrug resistance development (Fig. S1).</p>","PeriodicalId":10816,"journal":{"name":"Current cancer drug targets","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current cancer drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1568009626999260619162126","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

In the article titled "Influence of DNA Copy Number Aberrations in ABC Transporter Family Genes on the Survival of Patients with Primary Operatable Non-Small Cell Lung Cancer", published in Current Cancer Drug Targets, 2026, 26(2), 256-267 [1], Figure 6 was erroneously cited in the text. The original article can be found online at: https://www.benthamscience.com/issue/14684. Details of the correction are as follows: Original: Therefore, in vitro experiments showed changes in ABC-transporter genes expression profile after chemotherapy drugs expo-sure. Increase in the expression levels of genes in chemotherapy drugs resistant clones may indicate their involvement in multidrug resistance development (Fig. 6). Corrected: Therefore, in vitro experiments showed changes in ABC-transporter genes expression profile after chemotherapy drugs expo-sure. Increase in the expression levels of genes in chemotherapy drugs resistant clones may indicate their involvement in multidrug resistance development (Fig. S1).

查看原文本刊更多论文

ABC转运蛋白家族基因DNA拷贝数畸变对原发性可手术非小细胞肺癌患者生存的影响

发表于《Current Cancer Drug Targets》，2026,26(2),256-267 b[1]，题为“ABC转运蛋白家族基因DNA拷贝数畸变对原发性可手术非小细胞肺癌患者生存的影响”的文章中，图6被错误引用。原文可在https://www.benthamscience.com/issue/14684网站上找到。更正的细节如下：原文：因此，体外实验显示，化疗药物暴露后，abc转运体基因表达谱发生了变化。化疗耐药克隆中基因表达水平的增加可能表明它们参与了多药耐药的发展（图6）。更正：因此，体外实验显示，化疗药物暴露后，abc转运蛋白基因表达谱发生了变化。化疗耐药克隆中基因表达水平的增加可能表明它们参与了多药耐药的发展（图S1）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current cancer drug targets 医学-肿瘤学

CiteScore

5.40

自引率

0.00%

发文量

105

审稿时长

1 months

期刊介绍： Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes. Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer. As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.